Home » Topics » Regulatory

Regulatory
RSS

FDA grants accelerated approval to Trumenba for prevention of meningococcal meningitis B

Oct. 30, 2014

FDA approves Baxter's Obizur for acquired hemophilia A

Oct. 27, 2014

FDA approves two idiopathic pulmonary fibrosis drugs ahead of schedule

Oct. 16, 2014

FDA approves netupitant/palonosetron combination for CINV

Oct. 13, 2014

FDA approves Harvoni for hepatitis C

Oct. 13, 2014

Approval in Japan for manufacturing and distribution of ripasudil hydrochloride hydrate

Oct. 1, 2014

FDA approves Otezla for the oral treatment of plaque psoriasis

Sep. 25, 2014

FDA approves Trulicity for type 2 diabetes

Sep. 19, 2014

Japanese approval of Aricept for dementia with Lewy bodies

Sep. 19, 2014

FDA approves naloxegol for opioid-induced constipation in patients with chronic pain

Sep. 17, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...